Ten-year survival in glioblastoma. A systematic review

•This is the largest cumulative descriptive study to date on the 10-year survival in GBM.•The 10-year survival rate in the population with GBM is established 0.71%.•OS was positively correlated with the length of PFS and inversely related with age at diagnosis. Glioblastoma (GBM) is among the most d...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical neuroscience Ročník 54; s. 7 - 13
Hlavní autori:	Tykocki, Tomasz, Eltayeb, Mohamed
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Scotland Elsevier Ltd 01.08.2018
Predmet:	10 years Brain Neoplasms - mortality Brain Neoplasms - surgery Disease-Free Survival Glioblastoma Glioblastoma - mortality Glioblastoma - surgery Humans Long-term survival Progression-free survival Survival Rate Time Factors Long-term survival 10 years Progression-free survival Glioblastoma
ISSN:	0967-5868, 1532-2653, 1532-2653
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	•This is the largest cumulative descriptive study to date on the 10-year survival in GBM.•The 10-year survival rate in the population with GBM is established 0.71%.•OS was positively correlated with the length of PFS and inversely related with age at diagnosis. Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst 5-year overall survival (OS) rates among all human cancers. The aim of this systematic review is to present all cases with OS of a decade or more and to perform a descriptive analysis of the group. This systematic review was conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. A comprehensive search for relevant articles was performed on PubMed, Embase and Google Scholar for a period until June 10, 2016, using the following search words: glioblastoma multiforme, glioblastoma, GBM, long-term survival/survivors. Reports containing cases with the long-term survival of 10 years or longer were included in the review. The search produced 36 studies with 162 cases published in the years 1950–2014. The rate of long survivors in the cohort studied was established 0.76%. Mean age at diagnosis, OS and PFS were 31.1 ± 11.1, 15.9 ± 6.3, 11.9 ± 5.6 years respectively. Total and subtotal resections were found in 82 and 58 patients respectively. Nine cases received a biopsy alone. No statistical differences were found in a comparison of PFS, OS and age between total and subtotal resection groups. A regression analysis showed a significant correlation between PFS and OS, with an inverse relationship stated between age at diagnosis and OS. The 10-year survival rate in the cohort studied with GBM was estimated 0.71%. OS was positively correlated with the length of PFS and inversely related with age at diagnosis.
AbstractList	•This is the largest cumulative descriptive study to date on the 10-year survival in GBM.•The 10-year survival rate in the population with GBM is established 0.71%.•OS was positively correlated with the length of PFS and inversely related with age at diagnosis. Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst 5-year overall survival (OS) rates among all human cancers. The aim of this systematic review is to present all cases with OS of a decade or more and to perform a descriptive analysis of the group. This systematic review was conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. A comprehensive search for relevant articles was performed on PubMed, Embase and Google Scholar for a period until June 10, 2016, using the following search words: glioblastoma multiforme, glioblastoma, GBM, long-term survival/survivors. Reports containing cases with the long-term survival of 10 years or longer were included in the review. The search produced 36 studies with 162 cases published in the years 1950–2014. The rate of long survivors in the cohort studied was established 0.76%. Mean age at diagnosis, OS and PFS were 31.1 ± 11.1, 15.9 ± 6.3, 11.9 ± 5.6 years respectively. Total and subtotal resections were found in 82 and 58 patients respectively. Nine cases received a biopsy alone. No statistical differences were found in a comparison of PFS, OS and age between total and subtotal resection groups. A regression analysis showed a significant correlation between PFS and OS, with an inverse relationship stated between age at diagnosis and OS. The 10-year survival rate in the cohort studied with GBM was estimated 0.71%. OS was positively correlated with the length of PFS and inversely related with age at diagnosis. Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst 5-year overall survival (OS) rates among all human cancers. The aim of this systematic review is to present all cases with OS of a decade or more and to perform a descriptive analysis of the group. This systematic review was conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. A comprehensive search for relevant articles was performed on PubMed, Embase and Google Scholar for a period until June 10, 2016, using the following search words: glioblastoma multiforme, glioblastoma, GBM, long-term survival/survivors. Reports containing cases with the long-term survival of 10 years or longer were included in the review. The search produced 36 studies with 162 cases published in the years 1950-2014. The rate of long survivors in the cohort studied was established 0.76%. Mean age at diagnosis, OS and PFS were 31.1 ± 11.1, 15.9 ± 6.3, 11.9 ± 5.6 years respectively. Total and subtotal resections were found in 82 and 58 patients respectively. Nine cases received a biopsy alone. No statistical differences were found in a comparison of PFS, OS and age between total and subtotal resection groups. A regression analysis showed a significant correlation between PFS and OS, with an inverse relationship stated between age at diagnosis and OS. The 10-year survival rate in the cohort studied with GBM was estimated 0.71%. OS was positively correlated with the length of PFS and inversely related with age at diagnosis. Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst 5-year overall survival (OS) rates among all human cancers. The aim of this systematic review is to present all cases with OS of a decade or more and to perform a descriptive analysis of the group. This systematic review was conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. A comprehensive search for relevant articles was performed on PubMed, Embase and Google Scholar for a period until June 10, 2016, using the following search words: glioblastoma multiforme, glioblastoma, GBM, long-term survival/survivors. Reports containing cases with the long-term survival of 10 years or longer were included in the review. The search produced 36 studies with 162 cases published in the years 1950-2014. The rate of long survivors in the cohort studied was established 0.76%. Mean age at diagnosis, OS and PFS were 31.1 ± 11.1, 15.9 ± 6.3, 11.9 ± 5.6 years respectively. Total and subtotal resections were found in 82 and 58 patients respectively. Nine cases received a biopsy alone. No statistical differences were found in a comparison of PFS, OS and age between total and subtotal resection groups. A regression analysis showed a significant correlation between PFS and OS, with an inverse relationship stated between age at diagnosis and OS. The 10-year survival rate in the cohort studied with GBM was estimated 0.71%. OS was positively correlated with the length of PFS and inversely related with age at diagnosis.Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst 5-year overall survival (OS) rates among all human cancers. The aim of this systematic review is to present all cases with OS of a decade or more and to perform a descriptive analysis of the group. This systematic review was conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. A comprehensive search for relevant articles was performed on PubMed, Embase and Google Scholar for a period until June 10, 2016, using the following search words: glioblastoma multiforme, glioblastoma, GBM, long-term survival/survivors. Reports containing cases with the long-term survival of 10 years or longer were included in the review. The search produced 36 studies with 162 cases published in the years 1950-2014. The rate of long survivors in the cohort studied was established 0.76%. Mean age at diagnosis, OS and PFS were 31.1 ± 11.1, 15.9 ± 6.3, 11.9 ± 5.6 years respectively. Total and subtotal resections were found in 82 and 58 patients respectively. Nine cases received a biopsy alone. No statistical differences were found in a comparison of PFS, OS and age between total and subtotal resection groups. A regression analysis showed a significant correlation between PFS and OS, with an inverse relationship stated between age at diagnosis and OS. The 10-year survival rate in the cohort studied with GBM was estimated 0.71%. OS was positively correlated with the length of PFS and inversely related with age at diagnosis.
Author	Eltayeb, Mohamed Tykocki, Tomasz
Author_xml	– sequence: 1 givenname: Tomasz surname: Tykocki fullname: Tykocki, Tomasz email: ttomasz@mp.pl organization: Department of Neurosurgery, Western Hospital in Grodzisk Mazowiecki, Poland – sequence: 2 givenname: Mohamed orcidid: 0000-0003-3979-9393 surname: Eltayeb fullname: Eltayeb, Mohamed organization: Royal Victoria Infirmary, NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29801989$$D View this record in MEDLINE/PubMed
BookMark	eNqFkDtv2zAURokiReM8_kCGQGMXqZekKFJBl8DoCzDQxTtBUVcFXYp0SNmF_31kOMmQwZ3ucs4H3HNFLkIMSMgdhYoCbb5sqk20oWJAVQWiAmAfyIIKzkrWCH5BFtA2shSqUZfkKucNALQ1h0_kkrUKaKvaBWnWGMoDmlTkXdq7vfGFC8Uf72LnTZ7iaKrisciHPOFoJmeLhHuH_27Ix8H4jLcv95qsv39bL3-Wq98_fi0fV6WtQU6l7Woje8aVtCC4HJqadT0MVCpUDUdra9lRIxpgXS1QsYEPkvYDAq0tl4pfk8-n2W2KTzvMkx5dtui9CRh3WTOoBVOtoHJG71_QXTdir7fJjSYd9OurM8BOgE0x54TDG0JBH3vqjT721MeeGoSee86SeidZN80dYpiScf68-vWk4txnbpZ0tg6Dxd4ltJPuozuvP7zTrXfBWeP_4uF_8jMon6LW
CitedBy_id	crossref_primary_10_1016_j_canep_2021_101948 crossref_primary_10_1007_s11060_025_05080_3 crossref_primary_10_1080_00207454_2022_2098734 crossref_primary_10_1016_j_saa_2024_125063 crossref_primary_10_3389_fonc_2022_870843 crossref_primary_10_3390_cancers16020397 crossref_primary_10_3389_fimmu_2022_897754 crossref_primary_10_1007_s11060_019_03357_y crossref_primary_10_1016_j_heliyon_2024_e31175 crossref_primary_10_1038_s41419_021_04259_6 crossref_primary_10_1016_j_bcp_2020_113814 crossref_primary_10_1016_S1474_4422_23_00031_5 crossref_primary_10_1172_JCI186034 crossref_primary_10_1016_j_anndiagpath_2022_151899 crossref_primary_10_3390_metabo12030243 crossref_primary_10_1111_jocn_16499 crossref_primary_10_1002_adtp_202000124 crossref_primary_10_3390_ijms21124245 crossref_primary_10_1007_s12031_024_02218_2 crossref_primary_10_1097_WNR_0000000000001611 crossref_primary_10_1194_jlr_R088518 crossref_primary_10_1172_JCI178628 crossref_primary_10_3389_fonc_2022_912101 crossref_primary_10_3389_fendo_2021_728088 crossref_primary_10_1007_s12032_023_02079_6 crossref_primary_10_1016_j_wneu_2021_01_103 crossref_primary_10_1097_MD_0000000000033569 crossref_primary_10_1093_neuros_nyaa190 crossref_primary_10_1155_bmri_2004975 crossref_primary_10_3390_biomedicines12102327 crossref_primary_10_3390_cancers13071560 crossref_primary_10_1142_S0192415X21500361 crossref_primary_10_1016_j_wneu_2024_05_080 crossref_primary_10_1177_00368504231223353 crossref_primary_10_1111_nan_13016 crossref_primary_10_2147_CMAR_S252772 crossref_primary_10_1007_s12032_023_02071_0 crossref_primary_10_1093_brain_awac450 crossref_primary_10_1016_j_jocn_2021_04_043 crossref_primary_10_3390_cancers16081557 crossref_primary_10_3390_ijms221910454 crossref_primary_10_1136_jitc_2020_001937 crossref_primary_10_3390_cells12192354 crossref_primary_10_1002_ima_22869 crossref_primary_10_1136_bcr_2020_241026 crossref_primary_10_3390_cancers13133202 crossref_primary_10_1002_hsr2_1366 crossref_primary_10_1007_s11060_021_03932_2 crossref_primary_10_3171_2021_11_FOCUS21556 crossref_primary_10_2217_bmm_2019_0448 crossref_primary_10_3390_cancers14153822 crossref_primary_10_3390_pharmaceutics15041134 crossref_primary_10_3171_CASE22129 crossref_primary_10_1042_BSR20231400 crossref_primary_10_1007_s12640_022_00548_w crossref_primary_10_3892_ol_2019_10978 crossref_primary_10_3390_cancers10120492 crossref_primary_10_3389_fgene_2022_903117 crossref_primary_10_1016_j_ejmech_2021_113909 crossref_primary_10_1016_j_freeradbiomed_2022_11_028 crossref_primary_10_1016_j_wneu_2023_04_020 crossref_primary_10_1097_RLU_0000000000005365 crossref_primary_10_1038_s41598_019_42313_8 crossref_primary_10_1038_s41598_023_33872_y crossref_primary_10_1186_s12957_025_03858_3 crossref_primary_10_1016_j_jns_2019_116518 crossref_primary_10_3390_cancers13174255 crossref_primary_10_35371_aoem_2024_36_e17 crossref_primary_10_3390_molecules25092170 crossref_primary_10_1002_cam4_4016 crossref_primary_10_3390_ijms26010330 crossref_primary_10_1016_j_yexmp_2021_104655 crossref_primary_10_1093_neuonc_noaf181 crossref_primary_10_1111_jcmm_70842 crossref_primary_10_1093_neuros_nyaa243 crossref_primary_10_1186_s12967_025_06101_5 crossref_primary_10_1007_s40265_022_01702_6 crossref_primary_10_3390_brainsci15020146 crossref_primary_10_1038_s41568_022_00486_x crossref_primary_10_1111_ejn_16309 crossref_primary_10_2147_CMAR_S287676 crossref_primary_10_1097_NRL_0000000000000564 crossref_primary_10_1093_neuonc_noaa250 crossref_primary_10_1371_journal_pgen_1011314 crossref_primary_10_2217_cns_2022_0017 crossref_primary_10_3390_cancers11081060 crossref_primary_10_1021_jacs_4c11930 crossref_primary_10_1038_s41598_024_76826_8 crossref_primary_10_1016_j_wneu_2022_08_049 crossref_primary_10_3389_fimmu_2023_1299064 crossref_primary_10_1016_j_virusres_2023_199112 crossref_primary_10_31083_JIN23389 crossref_primary_10_3390_cancers15133298 crossref_primary_10_1007_s11060_023_04397_1 crossref_primary_10_1155_2024_5582424 crossref_primary_10_1016_j_jbior_2019_100658 crossref_primary_10_3390_app14072872 crossref_primary_10_1186_s12916_024_03775_4 crossref_primary_10_3390_cells10071609 crossref_primary_10_1016_j_nec_2020_08_002 crossref_primary_10_3171_CASE21630 crossref_primary_10_1016_j_cclet_2024_110228 crossref_primary_10_1002_jcp_28929 crossref_primary_10_1097_MD_0000000000038794 crossref_primary_10_3390_ijms242015206 crossref_primary_10_1097_RLU_0000000000004167 crossref_primary_10_4103_jcrt_jcrt_2248_21 crossref_primary_10_2147_CMAR_S250166 crossref_primary_10_1038_s41598_024_80596_8 crossref_primary_10_1186_s12967_024_05650_5 crossref_primary_10_31083_j_fbl2910341 crossref_primary_10_1016_j_intimp_2024_113219 crossref_primary_10_1111_bcpt_13515 crossref_primary_10_1155_2020_1798147 crossref_primary_10_3390_cancers13122867 crossref_primary_10_1016_j_wneu_2021_01_089 crossref_primary_10_1097_WNR_0000000000001226 crossref_primary_10_1002_advs_202413367 crossref_primary_10_3390_ijms25031398 crossref_primary_10_1007_s11060_020_03451_6 crossref_primary_10_3390_curroncol32040242 crossref_primary_10_25259_SNI_538_2020 crossref_primary_10_2147_CMAR_S322351 crossref_primary_10_1007_s10142_023_01010_6 crossref_primary_10_3390_pharmaceutics15102430 crossref_primary_10_1002_jbio_201960077 crossref_primary_10_1016_j_addr_2022_114415 crossref_primary_10_3390_biomedicines10112799 crossref_primary_10_3389_fneur_2022_832944 crossref_primary_10_2217_cns_2018_0010 crossref_primary_10_1007_s10143_022_01754_y crossref_primary_10_3389_fneur_2021_679745 crossref_primary_10_3390_brainsci14070633 crossref_primary_10_3390_cancers17050834 crossref_primary_10_2174_0113816128306113240328050608 crossref_primary_10_1186_s41181_024_00290_y crossref_primary_10_17116_jnevro202412406154 crossref_primary_10_1186_s12885_021_08592_z crossref_primary_10_1007_s11060_023_04444_x crossref_primary_10_1016_j_jconrel_2024_10_004 crossref_primary_10_1002_bab_70042 crossref_primary_10_1016_j_neucie_2021_11_001 crossref_primary_10_3390_ijms24031879 crossref_primary_10_1039_D3SC01315D crossref_primary_10_7759_cureus_16061 crossref_primary_10_1038_s41598_019_39273_4 crossref_primary_10_2147_IJN_S405454 crossref_primary_10_1186_s13046_024_03027_6 crossref_primary_10_1172_JCI128994 crossref_primary_10_3390_app13095434 crossref_primary_10_7759_cureus_24246 crossref_primary_10_1007_s11060_023_04481_6 crossref_primary_10_1159_000522611 crossref_primary_10_2174_1874467213666200512075507 crossref_primary_10_1186_s12943_025_02267_0 crossref_primary_10_3389_fmolb_2022_889971 crossref_primary_10_3390_app122010533 crossref_primary_10_1007_s12035_020_02088_w crossref_primary_10_1002_cam4_5681 crossref_primary_10_1016_j_intimp_2020_106336 crossref_primary_10_1172_jci_insight_187684 crossref_primary_10_1016_j_bbagen_2024_130567 crossref_primary_10_32604_phyton_2021_013305 crossref_primary_10_3892_mi_2025_245 crossref_primary_10_1007_s10456_022_09830_z crossref_primary_10_1002_adhm_202001600 crossref_primary_10_1002_cncr_34120 crossref_primary_10_3390_ijms25179714 crossref_primary_10_3390_ijms25052563 crossref_primary_10_3390_brainsci13071091 crossref_primary_10_1016_j_radonc_2021_05_002 crossref_primary_10_1097_PPO_0000000000000544 crossref_primary_10_1016_j_jcis_2025_139082 crossref_primary_10_3390_photonics8010022 crossref_primary_10_1038_s41420_025_02408_w crossref_primary_10_1093_nop_npaa039 crossref_primary_10_1007_s00330_020_07471_8 crossref_primary_10_1016_j_ejphar_2022_174837 crossref_primary_10_1016_j_colsurfb_2025_114668 crossref_primary_10_1007_s11060_021_03933_1 crossref_primary_10_1093_noajnl_vdaf129 crossref_primary_10_1097_MD_0000000000043636 crossref_primary_10_1038_s41467_022_34462_8 crossref_primary_10_1186_s12885_023_10596_w crossref_primary_10_3390_brainsci13060868 crossref_primary_10_3390_cancers14215377 crossref_primary_10_1016_j_brainres_2025_149529 crossref_primary_10_1155_2023_1680634 crossref_primary_10_1007_s00432_023_05528_x crossref_primary_10_1016_j_bbcan_2023_189059 crossref_primary_10_1007_s10616_020_00411_w crossref_primary_10_1007_s10528_024_10716_6 crossref_primary_10_1080_00207454_2020_1865950 crossref_primary_10_3389_fonc_2022_1014455 crossref_primary_10_3390_cancers15153845 crossref_primary_10_4103_NRR_NRR_D_24_00048 crossref_primary_10_1186_s41984_024_00294_5 crossref_primary_10_1002_jcb_28883 crossref_primary_10_1186_s12935_021_02036_1 crossref_primary_10_3389_fimmu_2025_1582296 crossref_primary_10_1016_j_wneu_2023_04_086 crossref_primary_10_1016_j_pharmthera_2023_108518 crossref_primary_10_1097_WCO_0000000000001213 crossref_primary_10_1007_s11060_025_04993_3 crossref_primary_10_1007_s11055_024_01717_4 crossref_primary_10_1093_carcin_bgz069 crossref_primary_10_25259_SNI_158_2024 crossref_primary_10_1007_s10142_025_01557_6 crossref_primary_10_1007_s12668_025_02101_3 crossref_primary_10_1016_S1875_5364_20_30012_1 crossref_primary_10_2217_fon_2019_0538 crossref_primary_10_3390_diagnostics12092125 crossref_primary_10_3389_fonc_2021_667884 crossref_primary_10_3390_cancers13153750 crossref_primary_10_1016_j_omtn_2023_01_003 crossref_primary_10_3389_fimmu_2025_1472710 crossref_primary_10_3390_diagnostics15111377 crossref_primary_10_1111_acel_13864
Cites_doi	10.1227/00006123-199305000-00003 10.3171/jns.2001.95.2.0190 10.1093/brain/awm204 10.1007/BF01401905 10.1177/030089169808400115 10.1007/s11060-016-2096-y 10.1016/S0360-3016(98)90036-0 10.1159/000339319 10.1159/000115440 10.1212/01.wnl.0000194221.89948.a0 10.1111/j.1750-3639.1993.tb00752.x 10.1227/00006123-199504000-00044 10.1007/BF00165483 10.3171/jns.2001.94.4.0605 10.3171/jns.1965.22.4.0382 10.1016/S1474-4422(05)70118-6 10.1227/00006123-198505000-00027 10.1186/1748-717X-9-95 10.1016/0360-3016(92)91021-E 10.1001/jamaoncol.2016.1373 10.7812/TPP/08-027 10.1016/j.ijrobp.2008.12.054 10.1227/00006123-199402000-00002 10.1093/neuonc/nou223 10.1007/s11060-012-0893-5 10.3171/jns.1950.7.3.0261 10.1002/cncr.30160 10.2176/nmc.40.224 10.1111/ane.12481 10.1017/S031716710000679X 10.1111/neup.12022 10.1080/02688690701885603 10.3171/jns.1991.74.5.0813 10.1007/s11060-009-9946-9 10.1093/neuonc/now117 10.1023/A:1017926603341 10.1200/JCO.2010.32.4343 10.3109/02841856609139538 10.1097/SMJ.0b013e3181d743fb 10.3171/jns.2006.104.3.360 10.1007/BF02427606 10.1016/0090-3019(81)90147-6 10.1093/annonc/mdq187 10.1007/s003810050228 10.1007/s00415-009-5167-6 10.1002/ana.410280614 10.3171/jns.1960.17.4.0736 10.1097/MPH.0000000000000020 10.1016/0090-3019(92)90022-F 10.1007/s00701-009-0387-1 10.1002/cncr.27590 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7 10.3171/jns.1988.69.4.0506 10.1016/S1470-2045(06)70665-9 10.4103/0028-3886.16934 10.1007/s004150070175 10.3171/jns.1986.65.5.0654 10.1177/030089169708300228
ContentType	Journal Article
Copyright	2018 Elsevier Ltd Copyright © 2018 Elsevier Ltd. All rights reserved.
Copyright_xml	– notice: 2018 Elsevier Ltd – notice: Copyright © 2018 Elsevier Ltd. All rights reserved.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.jocn.2018.05.002
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1532-2653
EndPage	13
ExternalDocumentID	29801989 10_1016_j_jocn_2018_05_002 S0967586817317216
Genre	Systematic Review Journal Article
GroupedDBID	--- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABJNI ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HVGLF HZ~ IHE J1W KOM LX8 M29 M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSN SSZ T5K UHS WUQ Z5R ~G- ~HD AACTN AADPK AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW LCYCR RIG 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c407t-cb4a7d2387c0537f642bd0f178e863ecc47b1a5602b45e82f3f71dfe014c3783
ISICitedReferencesCount	273
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000439673900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0967-5868 1532-2653
IngestDate	Sat Sep 27 17:56:19 EDT 2025 Mon Jul 21 06:02:05 EDT 2025 Tue Nov 18 22:13:52 EST 2025 Sat Nov 29 02:57:29 EST 2025 Fri Feb 23 02:26:33 EST 2024 Tue Oct 14 19:30:43 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Keywords	Long-term survival 10 years Progression-free survival Glioblastoma
Language	English
License	Copyright © 2018 Elsevier Ltd. All rights reserved.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c407t-cb4a7d2387c0537f642bd0f178e863ecc47b1a5602b45e82f3f71dfe014c3783
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4
ORCID	0000-0003-3979-9393
PMID	29801989
PQID	2045289517
PQPubID	23479
PageCount	7
ParticipantIDs	proquest_miscellaneous_2045289517 pubmed_primary_29801989 crossref_primary_10_1016_j_jocn_2018_05_002 crossref_citationtrail_10_1016_j_jocn_2018_05_002 elsevier_sciencedirect_doi_10_1016_j_jocn_2018_05_002 elsevier_clinicalkey_doi_10_1016_j_jocn_2018_05_002
PublicationCentury	2000
PublicationDate	August 2018 2018-08-00 2018-Aug 20180801
PublicationDateYYYYMMDD	2018-08-01
PublicationDate_xml	– month: 08 year: 2018 text: August 2018
PublicationDecade	2010
PublicationPlace	Scotland
PublicationPlace_xml	– name: Scotland
PublicationTitle	Journal of clinical neuroscience
PublicationTitleAlternate	J Clin Neurosci
PublicationYear	2018
Publisher	Elsevier Ltd
Publisher_xml	– name: Elsevier Ltd
References	Sami Walid (b0225) 2010; 103 Rong, Yang, Garzon-Muvdi, Caplan, Hui, Lim (b0255) 2016; 122 Hatanaka, Sano, Kitamura, Fukui, Mogami, Ushio (b0135) 1984; 27 Dehdashti, Sharma, Laperriere, Bernstein (b0115) 2007; 34 Brown, Brennan, Li, Church, Brandmeir, Rakszawski (b0265) 2016; 2 Stummer, Pichlmeier, Meinel, Wiestler, Zanella, Reulen (b0015) 2006; 7 Hottinger, Yoon, DeAngelis, Abrey (b0140) 2009; 95 Netsky, August, Fowler (b0180) 1950; 7 Albert, Forsting, Sartor, Adams, Kunze (b0290) 1994; 34 Burzynski, Janicki, Burzynski, Marszalek (b0100) 2014; 36 Vertosick, Selker (b0240) 1992; 38 Gullotta, Bettag (b0130) 1967; 16 Rutz, de Tribolet, Calmes, Chapuis (b0200) 1991; 74 Fekete, Werlenius, Örndal, Rydenhag (b0250) 2016; 133 McCarthy, Propp, Davis, Burger (b0310) 2008; 30 Anderson, Grant, Lewis, Whittle (b0025) 2008; 22 Choucair, Levin, Gutin, Davis, Silver, Edwards (b0045) 1986; 65 Willems, Taphoorn, Burger, Berkelbach van der Sprenkel, Tulleken (b0300) 2006; 104 Imperato, Paleologos, Vick (b0145) 1990; 28 Jung, Yoo, Kong, Won, Park, Lee (b0155) 2012; 109 Adeberg, Bostel, König, Welzel, Debus, Combs (b0030) 2014; 9 Gaspar, Fisher, Macdonald, LeBer, Halperin, Schold (b0050) 1992; 24 Roth, Elvidge (b0195) 1960; 17 Kumar, Deopujari, Karmarkar (b0165) 2012; 22 Puzzilli, Ruggeri, Mastronardi, Di Stefano, Lunardi (b0190) 1998; 84 Lobsiger, Jenzer, Locher (b0170) 1977; 48 Sperduto, Chakravarti, Aldape, Burger, Papermaster, Sperduto (b0230) 2009; 75 Johnson, Ma, Buckner, Hammack (b0280) 2012; 118 Morita, Rosenblum, Bilsky, Fraser, Rosenfeld (b0175) 1996; 27 Bucy, Oberhill, Siqueira, Zimmerman, Jelsma (b0095) 1985; 16 Polley, Lamborn, Chang, Butowski, Clarke, Prados (b0065) 2011; 29 Okolie, Bago, Schmid, Irvin, Bash, Miller (b0275) 2016 Bähr, Herrlinger, Weller, Steinbach (b0085) 2009; 256 Salcman, Scholtz, Kaplan, Kulik (b0210) 1994; 34 Halperin, Burger, Bullard (b0055) 1988; 15 Bouchard (b0090) 1966; 5 Sabel, Reifenberger, Weber, Reifenberger, Schmitt (b0205) 2001; 94 Steinbach, Blaicher, Herrlinger, Wick, Nägele, Meyermann (b0235) 2006; 66 Salford, Brun, Nirfalk (b0215) 1988; 69 Ostrom, Gittleman, Liao, Rouse, Chen, Dowling (b0075) 2014; 16 Johnson (b0150) 1981; 15 Sonoda, Kumabe, Watanabe, Nakazato, Inoue, Kanamori (b0040) 2009; 151 Fukushima, Narita, Miyakita, Ohno, Takizawa, Takusagawa (b0125) 2013; 33 Kleihues, Burger, Scheithauer (b0080) 1993; 3 Kraus, Wenghoefer, Schmidt, von Deimling, Berweiler, Roggendorf (b0305) 2000; 247 Elvidge, Barone (b0120) 1965; 22 Yoshida, Kawano, Oka, Fujii, Nakazato (b0245) 2000; 40 Salvati, Cervoni, Artico, Caruso, Gagliardi (b0220) 1998; 36 Mitchell, Ellison, Mendelow (b0295) 2005; 4 Chandler, Prados, Malec, Wilson (b0005) 1993; 32 Smoll, Schaller, Gautschi (b0070) 2012; 39 Krex, Klink, Hartmann, von Deimling, Pietsch, Simon (b0035) 2007; 130 Scott, Rewcastle, Brasher, Fulton, MacKinnon, Hamilton (b0060) 1999; 46 Klein, Mölenkamp, Sörensen, Roggendorf (b0160) 1998; 14 Pollak, Gur, Walach, Reif, Tamir, Schiffer (b0185) 1997; 83 Warnke, Kreth, Ostertag (b0285) 1995; 36 Walid (b0260) 2008; 12 Lacroix, Abi-Said, Fourney, Gokaslan, Shi, DeMonte (b0010) 2001; 95 Hamard, Ratel, Selek, Berger, van der Sanden, Wion (b0270) 2016; 128 Cervoni, Celli, Salvati (b0105) 1998; 19 Deb, Sharma, Mahapatra, Agarwal, Sarkar (b0110) 2005; 53 Stupp, Tonn, Brada, Pentheroudakis (b0020) 2010; 21 Fekete (10.1016/j.jocn.2018.05.002_b0250) 2016; 133 Rong (10.1016/j.jocn.2018.05.002_b0255) 2016; 122 Okolie (10.1016/j.jocn.2018.05.002_b0275) 2016 Adeberg (10.1016/j.jocn.2018.05.002_b0030) 2014; 9 Sami Walid (10.1016/j.jocn.2018.05.002_b0225) 2010; 103 Willems (10.1016/j.jocn.2018.05.002_b0300) 2006; 104 Brown (10.1016/j.jocn.2018.05.002_b0265) 2016; 2 Mitchell (10.1016/j.jocn.2018.05.002_b0295) 2005; 4 Albert (10.1016/j.jocn.2018.05.002_b0290) 1994; 34 Smoll (10.1016/j.jocn.2018.05.002_b0070) 2012; 39 Klein (10.1016/j.jocn.2018.05.002_b0160) 1998; 14 Salcman (10.1016/j.jocn.2018.05.002_b0210) 1994; 34 Puzzilli (10.1016/j.jocn.2018.05.002_b0190) 1998; 84 Fukushima (10.1016/j.jocn.2018.05.002_b0125) 2013; 33 Stummer (10.1016/j.jocn.2018.05.002_b0015) 2006; 7 Morita (10.1016/j.jocn.2018.05.002_b0175) 1996; 27 Walid (10.1016/j.jocn.2018.05.002_b0260) 2008; 12 Gaspar (10.1016/j.jocn.2018.05.002_b0050) 1992; 24 Stupp (10.1016/j.jocn.2018.05.002_b0020) 2010; 21 Sonoda (10.1016/j.jocn.2018.05.002_b0040) 2009; 151 Netsky (10.1016/j.jocn.2018.05.002_b0180) 1950; 7 Kraus (10.1016/j.jocn.2018.05.002_b0305) 2000; 247 Kumar (10.1016/j.jocn.2018.05.002_b0165) 2012; 22 Hottinger (10.1016/j.jocn.2018.05.002_b0140) 2009; 95 Lacroix (10.1016/j.jocn.2018.05.002_b0010) 2001; 95 Halperin (10.1016/j.jocn.2018.05.002_b0055) 1988; 15 Pollak (10.1016/j.jocn.2018.05.002_b0185) 1997; 83 Scott (10.1016/j.jocn.2018.05.002_b0060) 1999; 46 Rutz (10.1016/j.jocn.2018.05.002_b0200) 1991; 74 Lobsiger (10.1016/j.jocn.2018.05.002_b0170) 1977; 48 Hatanaka (10.1016/j.jocn.2018.05.002_b0135) 1984; 27 Ostrom (10.1016/j.jocn.2018.05.002_b0075) 2014; 16 Kleihues (10.1016/j.jocn.2018.05.002_b0080) 1993; 3 Anderson (10.1016/j.jocn.2018.05.002_b0025) 2008; 22 Cervoni (10.1016/j.jocn.2018.05.002_b0105) 1998; 19 Burzynski (10.1016/j.jocn.2018.05.002_b0100) 2014; 36 Steinbach (10.1016/j.jocn.2018.05.002_b0235) 2006; 66 Gullotta (10.1016/j.jocn.2018.05.002_b0130) 1967; 16 Vertosick (10.1016/j.jocn.2018.05.002_b0240) 1992; 38 Krex (10.1016/j.jocn.2018.05.002_b0035) 2007; 130 McCarthy (10.1016/j.jocn.2018.05.002_b0310) 2008; 30 Chandler (10.1016/j.jocn.2018.05.002_b0005) 1993; 32 Johnson (10.1016/j.jocn.2018.05.002_b0150) 1981; 15 Jung (10.1016/j.jocn.2018.05.002_b0155) 2012; 109 Hamard (10.1016/j.jocn.2018.05.002_b0270) 2016; 128 Elvidge (10.1016/j.jocn.2018.05.002_b0120) 1965; 22 Sperduto (10.1016/j.jocn.2018.05.002_b0230) 2009; 75 Yoshida (10.1016/j.jocn.2018.05.002_b0245) 2000; 40 Deb (10.1016/j.jocn.2018.05.002_b0110) 2005; 53 Imperato (10.1016/j.jocn.2018.05.002_b0145) 1990; 28 Roth (10.1016/j.jocn.2018.05.002_b0195) 1960; 17 Bähr (10.1016/j.jocn.2018.05.002_b0085) 2009; 256 Dehdashti (10.1016/j.jocn.2018.05.002_b0115) 2007; 34 Bouchard (10.1016/j.jocn.2018.05.002_b0090) 1966; 5 Sabel (10.1016/j.jocn.2018.05.002_b0205) 2001; 94 Salvati (10.1016/j.jocn.2018.05.002_b0220) 1998; 36 Johnson (10.1016/j.jocn.2018.05.002_b0280) 2012; 118 Warnke (10.1016/j.jocn.2018.05.002_b0285) 1995; 36 Polley (10.1016/j.jocn.2018.05.002_b0065) 2011; 29 Choucair (10.1016/j.jocn.2018.05.002_b0045) 1986; 65 Salford (10.1016/j.jocn.2018.05.002_b0215) 1988; 69 Bucy (10.1016/j.jocn.2018.05.002_b0095) 1985; 16
References_xml	– volume: 151 start-page: 1349 year: 2009 end-page: 1358 ident: b0040 article-title: Long-term survivors of glioblastoma: clinical features and molecular analysis publication-title: Acta Neurochir (Wien) – volume: 109 start-page: 301 year: 2012 end-page: 307 ident: b0155 article-title: Population-based survival data for brain tumors in Korea publication-title: J Neurooncol – volume: 34 start-page: 213 year: 1994 end-page: 219 ident: b0210 article-title: Long-term survival in patients with malignant astrocytoma publication-title: Neurosurgery – volume: 22 start-page: 378 year: 2012 end-page: 381 ident: b0165 article-title: A case of glioblastoma with long term survival: can we predict the outcome? publication-title: Turk Neurosurg – volume: 12 start-page: 45 year: 2008 end-page: 48 ident: b0260 article-title: Prognostic factors for long-term survival after glioblastoma publication-title: Perm J – volume: 94 start-page: 605 year: 2001 end-page: 611 ident: b0205 article-title: Long-term survival of a patient with giant cell glioblastoma. Case report publication-title: J Neurosurg – volume: 28 start-page: 818 year: 1990 end-page: 822 ident: b0145 article-title: Effects of treatment on long-term survivors with malignant astrocytomas publication-title: Ann Neurol – volume: 53 start-page: 329 year: 2005 end-page: 332 ident: b0110 article-title: Glioblastoma with long term survival publication-title: Neurol India – volume: 122 start-page: 3157 year: 2016 end-page: 3165 ident: b0255 article-title: Influence of insurance status on survival of adults with glioblastoma: a population-based study publication-title: Cancer – volume: 30 start-page: 34 year: 2008 end-page: 44 ident: b0310 article-title: Time trends in oligodendroglial and astrocytic tumor incidence publication-title: Neuroepidemiology – volume: 74 start-page: 813 year: 1991 end-page: 815 ident: b0200 article-title: Long-time survival of a patient with glioblastoma and Turcot’s syndrome. Case report publication-title: J Neurosurg – volume: 130 start-page: 2596 year: 2007 end-page: 2606 ident: b0035 article-title: Long-term survival with glioblastoma publication-title: Brain J Neurol – volume: 247 start-page: 455 year: 2000 end-page: 460 ident: b0305 article-title: Long-term survival of glioblastoma: importance of histopathological reevaluation publication-title: J Neurol – volume: 118 start-page: 5608 year: 2012 end-page: 5613 ident: b0280 article-title: Conditional probability of long-term survival in glioblastoma publication-title: Cancer – volume: 27 start-page: 259 year: 1996 end-page: 266 ident: b0175 article-title: Long-term survivors of glioblastoma: clinical and molecular characteristics publication-title: J Neurooncol – volume: 24 start-page: 55 year: 1992 end-page: 57 ident: b0050 article-title: Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment publication-title: Int J Radiat Oncol Biol Phys – volume: 7 start-page: 261 year: 1950 end-page: 269 ident: b0180 article-title: The longevity of patients with glioblastoma publication-title: J Neurosurg – volume: 16 start-page: 714 year: 1985 end-page: 717 ident: b0095 article-title: Cerebral glioblastomas can be cured! publication-title: Neurosurgery – volume: 27 start-page: 106 year: 1984 end-page: 110 ident: b0135 article-title: CT findings in patients with gliomas, surviving more than 10 years publication-title: Neurochirurgia (Stuttg) – volume: 14 start-page: 288 year: 1998 end-page: 291 ident: b0160 article-title: Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period publication-title: Childs Nerv Syst – volume: 133 start-page: 434 year: 2016 end-page: 441 ident: b0250 article-title: Prognostic factors for glioblastoma patients–a clinical population-based study publication-title: Acta Neurol Scand – volume: 256 start-page: 1756 year: 2009 end-page: 1758 ident: b0085 article-title: Very late relapses in glioblastoma long-term survivors publication-title: J Neurol – volume: 17 start-page: 736 year: 1960 end-page: 750 ident: b0195 article-title: Glioblastoma: a clinical survey publication-title: J Neurosurg – volume: 65 start-page: 654 year: 1986 end-page: 658 ident: b0045 article-title: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas publication-title: J Neurosurg – volume: 16 start-page: iv1 year: 2014 end-page: iv63 ident: b0075 article-title: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011 publication-title: Neuro Oncol – volume: 29 start-page: 4175 year: 2011 end-page: 4180 ident: b0065 article-title: Conditional probability of survival in patients with newly diagnosed glioblastoma publication-title: J Clin Oncol – volume: 15 start-page: 505 year: 1988 end-page: 509 ident: b0055 article-title: The fallacy of the localized supratentorial malignant glioma publication-title: Int J Radiat Oncol Biol Phys – volume: 33 start-page: 576 year: 2013 end-page: 581 ident: b0125 article-title: A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapy publication-title: Neuropathology – volume: 38 start-page: 359 year: 1992 end-page: 363 ident: b0240 article-title: Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis publication-title: Surg Neurol – volume: 128 start-page: 1 year: 2016 end-page: 8 ident: b0270 article-title: The brain tissue response to surgical injury and its possible contribution to glioma recurrence publication-title: J Neurooncol – year: 2016 ident: b0275 article-title: Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model publication-title: Neuro Oncol – volume: 104 start-page: 360 year: 2006 end-page: 368 ident: b0300 article-title: Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial publication-title: J Neurosurg – volume: 46 start-page: 183 year: 1999 end-page: 188 ident: b0060 article-title: Which glioblastoma patient will become a long-term survivor? A population-based study publication-title: Ann Neurol – volume: 9 start-page: 95 year: 2014 ident: b0030 article-title: A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? publication-title: Radiat Oncol Lond Engl – volume: 83 start-page: 613 year: 1997 end-page: 617 ident: b0185 article-title: Clinical determinants of long-term survival in patients with glioblastoma publication-title: Tumori – volume: 4 start-page: 413 year: 2005 end-page: 422 ident: b0295 article-title: Surgery for malignant gliomas: mechanistic reasoning and slippery statistics publication-title: Lancet Neurol – volume: 34 start-page: 45 year: 1994 end-page: 60 ident: b0290 article-title: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis publication-title: Neurosurgery – volume: 2 start-page: 1460 year: 2016 end-page: 1469 ident: b0265 article-title: Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis publication-title: JAMA Oncol – volume: 32 start-page: 716 year: 1993 end-page: 720 ident: b0005 article-title: Long-term survival in patients with glioblastoma publication-title: Neurosurgery – volume: 16 start-page: 122 year: 1967 end-page: 128 ident: b0130 article-title: On the question of longer survival time in glioblastomas publication-title: Acta Neurochir (Wien) – volume: 48 start-page: 626 year: 1977 end-page: 629 ident: b0170 article-title: Unusually long survival time in astrocytoma grade III–IV (author’s transl) publication-title: Nervenarzt – volume: 84 start-page: 69 year: 1998 end-page: 74 ident: b0190 article-title: Long-term survival in cerebral glioblastoma. Case report and critical review of the literature publication-title: Tumori – volume: 7 start-page: 392 year: 2006 end-page: 401 ident: b0015 article-title: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial publication-title: Lancet Oncol – volume: 3 start-page: 255 year: 1993 end-page: 268 ident: b0080 article-title: The new WHO classification of brain tumours publication-title: Brain Pathol Zurich Switz – volume: 19 start-page: 221 year: 1998 end-page: 224 ident: b0105 article-title: Long-term survival in a patient with supratentorial glioblastoma: clinical considerations publication-title: Ital J Neurol Sci – volume: 103 start-page: 590 year: 2010 end-page: 591 ident: b0225 article-title: Thirteen years’ survival after glioblastoma publication-title: South Med J – volume: 36 start-page: 61 year: 1998 end-page: 64 ident: b0220 article-title: Long-term survival in patients with supratentorial glioblastoma publication-title: J Neurooncol – volume: 69 start-page: 506 year: 1988 end-page: 509 ident: b0215 article-title: Ten-year survival among patients with supratentorial astrocytomas grade III and IV publication-title: J Neurosurgery – volume: 95 start-page: 301 year: 2009 end-page: 305 ident: b0140 article-title: Neurological outcome of long-term glioblastoma survivors publication-title: J Neurooncol – volume: 34 start-page: 339 year: 2007 end-page: 342 ident: b0115 article-title: Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy publication-title: Can J Neurol Sci – volume: 66 start-page: 239 year: 2006 end-page: 242 ident: b0235 article-title: Surviving glioblastoma for more than 5 years: the patient’s perspective publication-title: Neurology – volume: 22 start-page: 339 year: 2008 end-page: 349 ident: b0025 article-title: Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? publication-title: Br J Neurosurg – volume: 5 start-page: 11 year: 1966 end-page: 16 ident: b0090 article-title: Radiation therapy of intracranial tumors–long term results publication-title: Acta Radiol Ther Phys Biol – volume: 22 start-page: 382 year: 1965 end-page: 386 ident: b0120 article-title: Long-term postoperative survival in two cases of glioblastoma publication-title: J Neurosurg – volume: 40 start-page: 224 year: 2000 end-page: 229 ident: b0245 article-title: Clinical cure of glioblastoma–two case reports publication-title: Neurol Med Chir (Tokyo) – volume: 15 start-page: 217 year: 1981 end-page: 219 ident: b0150 article-title: Malignant intracranial tumor: report of three cases with long-term postoperative survival publication-title: Surg Neurol – volume: 39 start-page: 63 year: 2012 end-page: 69 ident: b0070 article-title: The cure fraction of glioblastoma publication-title: Neuroepidemiology – volume: 95 start-page: 190 year: 2001 end-page: 198 ident: b0010 article-title: A multivariate analysis of 416 patients with glioblastoma: prognosis, extent of resection, and survival publication-title: J Neurosurg – volume: 36 start-page: 872 year: 1995 end-page: 874 ident: b0285 article-title: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis publication-title: Neurosurgery – volume: 36 start-page: e433 year: 2014 end-page: e439 ident: b0100 article-title: Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report publication-title: J Pediatr Hematol Oncol – volume: 75 start-page: 1162 year: 2009 end-page: 1165 ident: b0230 article-title: Twenty-year survival in glioblastoma: a case report and molecular profile publication-title: Int J Radiat Oncol Biol Phys – volume: 21 start-page: v190 year: 2010 end-page: v193 ident: b0020 article-title: High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol – volume: 32 start-page: 716 year: 1993 ident: 10.1016/j.jocn.2018.05.002_b0005 article-title: Long-term survival in patients with glioblastoma publication-title: Neurosurgery doi: 10.1227/00006123-199305000-00003 – volume: 95 start-page: 190 year: 2001 ident: 10.1016/j.jocn.2018.05.002_b0010 article-title: A multivariate analysis of 416 patients with glioblastoma: prognosis, extent of resection, and survival publication-title: J Neurosurg doi: 10.3171/jns.2001.95.2.0190 – volume: 130 start-page: 2596 year: 2007 ident: 10.1016/j.jocn.2018.05.002_b0035 article-title: Long-term survival with glioblastoma publication-title: Brain J Neurol doi: 10.1093/brain/awm204 – volume: 16 start-page: 122 year: 1967 ident: 10.1016/j.jocn.2018.05.002_b0130 article-title: On the question of longer survival time in glioblastomas publication-title: Acta Neurochir (Wien) doi: 10.1007/BF01401905 – volume: 84 start-page: 69 year: 1998 ident: 10.1016/j.jocn.2018.05.002_b0190 article-title: Long-term survival in cerebral glioblastoma. Case report and critical review of the literature publication-title: Tumori doi: 10.1177/030089169808400115 – volume: 128 start-page: 1 year: 2016 ident: 10.1016/j.jocn.2018.05.002_b0270 article-title: The brain tissue response to surgical injury and its possible contribution to glioma recurrence publication-title: J Neurooncol doi: 10.1007/s11060-016-2096-y – volume: 15 start-page: 505 year: 1988 ident: 10.1016/j.jocn.2018.05.002_b0055 article-title: The fallacy of the localized supratentorial malignant glioma publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(98)90036-0 – volume: 39 start-page: 63 year: 2012 ident: 10.1016/j.jocn.2018.05.002_b0070 article-title: The cure fraction of glioblastoma publication-title: Neuroepidemiology doi: 10.1159/000339319 – volume: 30 start-page: 34 year: 2008 ident: 10.1016/j.jocn.2018.05.002_b0310 article-title: Time trends in oligodendroglial and astrocytic tumor incidence publication-title: Neuroepidemiology doi: 10.1159/000115440 – volume: 66 start-page: 239 year: 2006 ident: 10.1016/j.jocn.2018.05.002_b0235 article-title: Surviving glioblastoma for more than 5 years: the patient’s perspective publication-title: Neurology doi: 10.1212/01.wnl.0000194221.89948.a0 – volume: 3 start-page: 255 year: 1993 ident: 10.1016/j.jocn.2018.05.002_b0080 article-title: The new WHO classification of brain tumours publication-title: Brain Pathol Zurich Switz doi: 10.1111/j.1750-3639.1993.tb00752.x – volume: 36 start-page: 872 year: 1995 ident: 10.1016/j.jocn.2018.05.002_b0285 article-title: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis publication-title: Neurosurgery doi: 10.1227/00006123-199504000-00044 – volume: 34 start-page: 45 year: 1994 ident: 10.1016/j.jocn.2018.05.002_b0290 article-title: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis publication-title: Neurosurgery – volume: 27 start-page: 259 year: 1996 ident: 10.1016/j.jocn.2018.05.002_b0175 article-title: Long-term survivors of glioblastoma: clinical and molecular characteristics publication-title: J Neurooncol doi: 10.1007/BF00165483 – volume: 94 start-page: 605 year: 2001 ident: 10.1016/j.jocn.2018.05.002_b0205 article-title: Long-term survival of a patient with giant cell glioblastoma. Case report publication-title: J Neurosurg doi: 10.3171/jns.2001.94.4.0605 – volume: 22 start-page: 382 year: 1965 ident: 10.1016/j.jocn.2018.05.002_b0120 article-title: Long-term postoperative survival in two cases of glioblastoma publication-title: J Neurosurg doi: 10.3171/jns.1965.22.4.0382 – volume: 4 start-page: 413 year: 2005 ident: 10.1016/j.jocn.2018.05.002_b0295 article-title: Surgery for malignant gliomas: mechanistic reasoning and slippery statistics publication-title: Lancet Neurol doi: 10.1016/S1474-4422(05)70118-6 – volume: 16 start-page: 714 year: 1985 ident: 10.1016/j.jocn.2018.05.002_b0095 article-title: Cerebral glioblastomas can be cured! publication-title: Neurosurgery doi: 10.1227/00006123-198505000-00027 – volume: 9 start-page: 95 year: 2014 ident: 10.1016/j.jocn.2018.05.002_b0030 article-title: A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? publication-title: Radiat Oncol Lond Engl doi: 10.1186/1748-717X-9-95 – volume: 24 start-page: 55 year: 1992 ident: 10.1016/j.jocn.2018.05.002_b0050 article-title: Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/0360-3016(92)91021-E – volume: 2 start-page: 1460 year: 2016 ident: 10.1016/j.jocn.2018.05.002_b0265 article-title: Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2016.1373 – volume: 12 start-page: 45 year: 2008 ident: 10.1016/j.jocn.2018.05.002_b0260 article-title: Prognostic factors for long-term survival after glioblastoma publication-title: Perm J doi: 10.7812/TPP/08-027 – volume: 27 start-page: 106 year: 1984 ident: 10.1016/j.jocn.2018.05.002_b0135 article-title: CT findings in patients with gliomas, surviving more than 10 years publication-title: Neurochirurgia (Stuttg) – volume: 75 start-page: 1162 year: 2009 ident: 10.1016/j.jocn.2018.05.002_b0230 article-title: Twenty-year survival in glioblastoma: a case report and molecular profile publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.12.054 – volume: 34 start-page: 213 year: 1994 ident: 10.1016/j.jocn.2018.05.002_b0210 article-title: Long-term survival in patients with malignant astrocytoma publication-title: Neurosurgery doi: 10.1227/00006123-199402000-00002 – volume: 16 start-page: iv1 year: 2014 ident: 10.1016/j.jocn.2018.05.002_b0075 article-title: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011 publication-title: Neuro Oncol doi: 10.1093/neuonc/nou223 – volume: 109 start-page: 301 year: 2012 ident: 10.1016/j.jocn.2018.05.002_b0155 article-title: Population-based survival data for brain tumors in Korea publication-title: J Neurooncol doi: 10.1007/s11060-012-0893-5 – volume: 7 start-page: 261 year: 1950 ident: 10.1016/j.jocn.2018.05.002_b0180 article-title: The longevity of patients with glioblastoma publication-title: J Neurosurg doi: 10.3171/jns.1950.7.3.0261 – volume: 122 start-page: 3157 year: 2016 ident: 10.1016/j.jocn.2018.05.002_b0255 article-title: Influence of insurance status on survival of adults with glioblastoma: a population-based study publication-title: Cancer doi: 10.1002/cncr.30160 – volume: 22 start-page: 378 year: 2012 ident: 10.1016/j.jocn.2018.05.002_b0165 article-title: A case of glioblastoma with long term survival: can we predict the outcome? publication-title: Turk Neurosurg – volume: 40 start-page: 224 year: 2000 ident: 10.1016/j.jocn.2018.05.002_b0245 article-title: Clinical cure of glioblastoma–two case reports publication-title: Neurol Med Chir (Tokyo) doi: 10.2176/nmc.40.224 – volume: 133 start-page: 434 year: 2016 ident: 10.1016/j.jocn.2018.05.002_b0250 article-title: Prognostic factors for glioblastoma patients–a clinical population-based study publication-title: Acta Neurol Scand doi: 10.1111/ane.12481 – volume: 34 start-page: 339 year: 2007 ident: 10.1016/j.jocn.2018.05.002_b0115 article-title: Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy publication-title: Can J Neurol Sci doi: 10.1017/S031716710000679X – volume: 33 start-page: 576 year: 2013 ident: 10.1016/j.jocn.2018.05.002_b0125 article-title: A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapy publication-title: Neuropathology doi: 10.1111/neup.12022 – volume: 22 start-page: 339 year: 2008 ident: 10.1016/j.jocn.2018.05.002_b0025 article-title: Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? publication-title: Br J Neurosurg doi: 10.1080/02688690701885603 – volume: 74 start-page: 813 year: 1991 ident: 10.1016/j.jocn.2018.05.002_b0200 article-title: Long-time survival of a patient with glioblastoma and Turcot’s syndrome. Case report publication-title: J Neurosurg doi: 10.3171/jns.1991.74.5.0813 – volume: 95 start-page: 301 year: 2009 ident: 10.1016/j.jocn.2018.05.002_b0140 article-title: Neurological outcome of long-term glioblastoma survivors publication-title: J Neurooncol doi: 10.1007/s11060-009-9946-9 – year: 2016 ident: 10.1016/j.jocn.2018.05.002_b0275 article-title: Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model publication-title: Neuro Oncol doi: 10.1093/neuonc/now117 – volume: 36 start-page: 61 year: 1998 ident: 10.1016/j.jocn.2018.05.002_b0220 article-title: Long-term survival in patients with supratentorial glioblastoma publication-title: J Neurooncol doi: 10.1023/A:1017926603341 – volume: 29 start-page: 4175 year: 2011 ident: 10.1016/j.jocn.2018.05.002_b0065 article-title: Conditional probability of survival in patients with newly diagnosed glioblastoma publication-title: J Clin Oncol doi: 10.1200/JCO.2010.32.4343 – volume: 5 start-page: 11 year: 1966 ident: 10.1016/j.jocn.2018.05.002_b0090 article-title: Radiation therapy of intracranial tumors–long term results publication-title: Acta Radiol Ther Phys Biol doi: 10.3109/02841856609139538 – volume: 48 start-page: 626 year: 1977 ident: 10.1016/j.jocn.2018.05.002_b0170 article-title: Unusually long survival time in astrocytoma grade III–IV (author’s transl) publication-title: Nervenarzt – volume: 103 start-page: 590 year: 2010 ident: 10.1016/j.jocn.2018.05.002_b0225 article-title: Thirteen years’ survival after glioblastoma publication-title: South Med J doi: 10.1097/SMJ.0b013e3181d743fb – volume: 104 start-page: 360 year: 2006 ident: 10.1016/j.jocn.2018.05.002_b0300 article-title: Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial publication-title: J Neurosurg doi: 10.3171/jns.2006.104.3.360 – volume: 19 start-page: 221 year: 1998 ident: 10.1016/j.jocn.2018.05.002_b0105 article-title: Long-term survival in a patient with supratentorial glioblastoma: clinical considerations publication-title: Ital J Neurol Sci doi: 10.1007/BF02427606 – volume: 15 start-page: 217 year: 1981 ident: 10.1016/j.jocn.2018.05.002_b0150 article-title: Malignant intracranial tumor: report of three cases with long-term postoperative survival publication-title: Surg Neurol doi: 10.1016/0090-3019(81)90147-6 – volume: 21 start-page: v190 issue: Suppl 5 year: 2010 ident: 10.1016/j.jocn.2018.05.002_b0020 article-title: High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdq187 – volume: 14 start-page: 288 year: 1998 ident: 10.1016/j.jocn.2018.05.002_b0160 article-title: Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period publication-title: Childs Nerv Syst doi: 10.1007/s003810050228 – volume: 256 start-page: 1756 year: 2009 ident: 10.1016/j.jocn.2018.05.002_b0085 article-title: Very late relapses in glioblastoma long-term survivors publication-title: J Neurol doi: 10.1007/s00415-009-5167-6 – volume: 28 start-page: 818 year: 1990 ident: 10.1016/j.jocn.2018.05.002_b0145 article-title: Effects of treatment on long-term survivors with malignant astrocytomas publication-title: Ann Neurol doi: 10.1002/ana.410280614 – volume: 17 start-page: 736 year: 1960 ident: 10.1016/j.jocn.2018.05.002_b0195 article-title: Glioblastoma: a clinical survey publication-title: J Neurosurg doi: 10.3171/jns.1960.17.4.0736 – volume: 36 start-page: e433 year: 2014 ident: 10.1016/j.jocn.2018.05.002_b0100 article-title: Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report publication-title: J Pediatr Hematol Oncol doi: 10.1097/MPH.0000000000000020 – volume: 38 start-page: 359 year: 1992 ident: 10.1016/j.jocn.2018.05.002_b0240 article-title: Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis publication-title: Surg Neurol doi: 10.1016/0090-3019(92)90022-F – volume: 151 start-page: 1349 year: 2009 ident: 10.1016/j.jocn.2018.05.002_b0040 article-title: Long-term survivors of glioblastoma: clinical features and molecular analysis publication-title: Acta Neurochir (Wien) doi: 10.1007/s00701-009-0387-1 – volume: 118 start-page: 5608 year: 2012 ident: 10.1016/j.jocn.2018.05.002_b0280 article-title: Conditional probability of long-term survival in glioblastoma publication-title: Cancer doi: 10.1002/cncr.27590 – volume: 46 start-page: 183 year: 1999 ident: 10.1016/j.jocn.2018.05.002_b0060 article-title: Which glioblastoma patient will become a long-term survivor? A population-based study publication-title: Ann Neurol doi: 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7 – volume: 69 start-page: 506 year: 1988 ident: 10.1016/j.jocn.2018.05.002_b0215 article-title: Ten-year survival among patients with supratentorial astrocytomas grade III and IV publication-title: J Neurosurgery doi: 10.3171/jns.1988.69.4.0506 – volume: 7 start-page: 392 year: 2006 ident: 10.1016/j.jocn.2018.05.002_b0015 article-title: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(06)70665-9 – volume: 53 start-page: 329 year: 2005 ident: 10.1016/j.jocn.2018.05.002_b0110 article-title: Glioblastoma with long term survival publication-title: Neurol India doi: 10.4103/0028-3886.16934 – volume: 247 start-page: 455 year: 2000 ident: 10.1016/j.jocn.2018.05.002_b0305 article-title: Long-term survival of glioblastoma: importance of histopathological reevaluation publication-title: J Neurol doi: 10.1007/s004150070175 – volume: 65 start-page: 654 year: 1986 ident: 10.1016/j.jocn.2018.05.002_b0045 article-title: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas publication-title: J Neurosurg doi: 10.3171/jns.1986.65.5.0654 – volume: 83 start-page: 613 year: 1997 ident: 10.1016/j.jocn.2018.05.002_b0185 article-title: Clinical determinants of long-term survival in patients with glioblastoma publication-title: Tumori doi: 10.1177/030089169708300228
SSID	ssj0009430
Score	2.6136076
SecondaryResourceType	review_article
Snippet	•This is the largest cumulative descriptive study to date on the 10-year survival in GBM.•The 10-year survival rate in the population with GBM is established... Glioblastoma (GBM) is among the most deadly neoplasms associated with one of the worst 5-year overall survival (OS) rates among all human cancers. The aim of...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	7
SubjectTerms	10 years Brain Neoplasms - mortality Brain Neoplasms - surgery Disease-Free Survival Glioblastoma Glioblastoma - mortality Glioblastoma - surgery Humans Long-term survival Progression-free survival Survival Rate Time Factors
Title	Ten-year survival in glioblastoma. A systematic review
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0967586817317216 https://dx.doi.org/10.1016/j.jocn.2018.05.002 https://www.ncbi.nlm.nih.gov/pubmed/29801989 https://www.proquest.com/docview/2045289517
Volume	54
WOSCitedRecordID	wos000439673900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-2653 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwELYoVBWXqvTF9oFSqTeU1SZx1vZxVVFBBaiHHPZmObHT7hYSxGYp21_fcfzIsmh5HLhEUZSxknyT8Yw98w1CX8tEEiJyFmLJhiEmkoUwKaQhpZhiKZRIVFsofExOT-l4zH7aLn2ztp0AqSp6fc0unhRquAZg69LZR8DtB4ULcA6gwxFgh-PDgFdVuND0PLM5mIGrllRj_9fZpM7BUW7qc9EHY7BK4Px3jZPqCyeXeC-9KmSLP2BN23SATKcZ_esSQRqxUO1Oz0n9W5zbAiq7uBBRn9rmVwnBjqbUdL5xBjPFSxaPLE2dpqr0llE26wPT_rQuNONsRPtmIaubgty2-8rM5PMFXSralOsxuB6DD1LesohuxSRlYM-2RkcH4x8d4TJu-8z4F7AFUya3b_VJ1jkl64KO1vnIXqGXFpBgZNDeQRuqeo1enNi8iDdo6EAPHOjBpApugB6Mgg70wID-FmXfD7Jvh6HtiBEWEHg3YZFjQSR4WaTQPDwlBI-5HJQRoYoOE_gbMckjAU5snONU0bhMShLJUkEcXCSEJu_QZlVXahcFMFAuSSTkIJIYqyGIJ7lkqSjjgZAF7aHIfRFeWLZ43bTkjK_Hoof2vcyF4Uq58-7EfWjulBnmLQ5ac6dU6qWs0hvf7165Lw5LDgZU74qJStXzGdf9GGIKgQbpofcGZP_0MQMHjlH24VFv9hFtd__SJ7TZXM7VZ_S8uGoms8s99IyM6Z5V1__udpx6
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ten-year+survival+in+glioblastoma.+A+systematic+review&rft.jtitle=Journal+of+clinical+neuroscience&rft.au=Tykocki%2C+Tomasz&rft.au=Eltayeb%2C+Mohamed&rft.date=2018-08-01&rft.issn=0967-5868&rft.volume=54&rft.spage=7&rft.epage=13&rft_id=info:doi/10.1016%2Fj.jocn.2018.05.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jocn_2018_05_002
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0967-5868&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0967-5868&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0967-5868&client=summon